SEC Form 4 · accession 0001209191-15-056572
ZS Pharma, Inc. · ZSPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kimberly J Popovits
Director
Period of report
Jun 18, 2015
Accepted (ET)
Jun 25, 2015 · 8:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001459266
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options right to buyF1 | — | Jun 18, 2015 | A | 4,000 | A | — | — | Common Stock | 4,000 | 4,000 | D |
| Restricted Stock UnitF2 | — | Jun 18, 2015 | A | 1,000 | A | — | — | Common Stock | 1,000 | 1,000 | D |
Explanation of responses
- F1Ms. Popovits was granted an option to purchase 4,000 shares of common stock at an exercise price per share of $55.57 on June 18, 2015. This option vests in full on the earlier of the first anniversary of the date of grant or the date of the first annual meeting of the company's Stockholders that occurs after the date of grant, in each case subject to Ms. Popovits continuing to serve as a member of the board of directors of the company and to the terms of the option agreement accompanying the grant.
- F2On June 18, 2015, Ms. Popovits was granted 1,000 restricted stock units representing the right to receive one share of common stock upon vesting of each restricted stock unit. The restricted stock units vest in full on the earlier of the first anniversary of the date of grant or the date of the first annual meeting of the company's Stockholders that occurs after the date of grant, in each case subject to Ms. Popovits's continuing to serve as a member of the board of directors of the company.